AI assistant
Sending…
Armata Pharmaceuticals, Inc. — Director's Dealing 2019
May 17, 2019
34152_dirs_2019-05-17_37458e0c-a4a9-4879-b574-a9527f99035c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Armata Pharmaceuticals, Inc. (ARMP)
CIK: 0000921114
Period of Report: 2019-05-09
Reporting Person: Delta Dental Plan of Michigan, Inc. (10% Owner)
Reporting Person: Renaissance Holding Co (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1265802 | Indirect |
Footnotes
F1: Delta Dental Plan of Michigan, Inc. ("Delta") owns, directly or indirectly, approximately 68% of the outstanding common stock of Renaissance Holding Company, which directly owns the reported securities. Delta is an indirect beneficial owner of the reported securities.
More from Armata Pharmaceuticals, Inc.
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 27
Regulatory Filings
2026
Apr 27
Annual Report
2026
Mar 25
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Feb 23